Cargando…
Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study
BACKGROUND: In long QT syndrome (LQTS), beta blockers prevent arrhythmias. As a supplement, means to increase potassium has been suggested. We set to investigate the effect of moderate potassium elevation on cardiac repolarisation. METHODS: Patients with LQTS with a disease-causing KCNQ1 or KCNH2 va...
Autores principales: | Marstrand, Peter, Almatlouh, Kasim, Kanters, Jørgen K, Graff, Claus, Christensen, Alex Hørby, Bundgaard, Henning, Theilade, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449979/ https://www.ncbi.nlm.nih.gov/pubmed/34531279 http://dx.doi.org/10.1136/openhrt-2021-001670 |
Ejemplares similares
-
Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study
por: Jespersen, Camilla H B, et al.
Publicado: (2022) -
Paediatric/young versus adult patients with long QT syndrome
por: Lee, Sharen, et al.
Publicado: (2021) -
Familial risk of atrioventricular block in first-degree relatives
por: Dyssekilde, Johnni Resdal, et al.
Publicado: (2022) -
Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES)
por: Malik, Rehan, et al.
Publicado: (2017) -
Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)